genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Neuroscience
Brain Biomarker Predicts Compulsive Drinking
News
In Alzheimer’s, Inflammasome Drives Both Amyloid and Tau Pathology
Liver Diseases
Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership
Neuroscience
Omega-3 Fish Oil May Be Better for Attention Than ADHD Drugs…
News
Cancer: A DNA-Ring Circus Where Oncogenes Wreak Havoc
Insights
Insights
Treading with Caution
Bioprocessing
Gene Therapy Companies’ Demands Reshape CDMOs
Bioprocessing
Building Bioprocessing from Data
Cell Therapy
“Squeezing” Cells Could Transform Cell Therapy Manufacturing
Insights
2020 Vision: Predictions of What May Shape Precision Medicine
A-Lists
Drug Discovery
Top 10 Pharma Companies of 2019
A-Lists
Top 25 Biotech Companies of 2019
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
GEN Edge
Top 10 U.S. Biopharma Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Insights
Treading with Caution
Liver Diseases
Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership
News
Cancer: A DNA-Ring Circus Where Oncogenes Wreak Havoc
Eli Lilly
Eli Lilly Plans $400M Manufacturing Expansion
Magazine
November 2019 Vol. 39 No. 11
Synthetic Biology Seizes New Ground in Healthcare
November 2019 Vol. 39 No. 11
Agrigenomics Yields a Next-Gen Cornucopia
November 2019 Vol. 39 No. 11
Protein-Protein Interactions Get a New Groove On
Commentary
Machine Learning Enhances Cytometry Analysis
November 2019 Vol. 39 No. 11
Biomarker Specialists Team Up, Run Up the Companion Diagnostics Score
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Merck
Antibody Drug Conjugates: Manufacturing Precision Guided Therapeutics
GENcast
Antibody Drug Conjugates: Manufacturing Precision Guided Therapeutics
eBooks
Detecting HCP Impurities in the Bioproduction Haystack
Posters
Inertial Microfluidics Enables Highly Consistent Separation and Concentration of Leukocytes from…
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Liver Diseases
Liver Diseases
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Liver Diseases
Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership
Liver Diseases
Xenotransplant Developer eGenesis Raises $100M in Series B Financing
Liver Diseases
Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B
Liver Diseases
Lab-Grown Engineered Human Mini Livers Offer New Insights into NAFLD Drug Failure
Liver Diseases
Enzyme Associated with Detoxification Linked to Obesity and Fatty Liver Disease
Liver Diseases
Single-Cell RNA Seq Creates Human Liver Cell Atlas
Liver Diseases
Boehringer Ingelheim, Yuhan Launch Up-to-$870M+ NASH Collaboration
Liver Diseases
PROTACs Developed with U. of Dundee Boost Boehringer Ingelheim’s Cancer Pipeline
Liver Diseases
Genentech, Parvus Therapeutics Launch Up-to-$800M Autoimmune Collaboration
Liver Diseases
Gilead Sciences, insitro Launch Up-to-$1B+ AI-Based NASH Drug Collaboration
Liver Diseases
Alnylam, Regeneron Launch $1B RNAi Collaboration Focused on Eye, CNS, Liver...
Liver Diseases
Pfizer Gains Option to Buy Rare Disease Gene Therapy Developer Vivet...
Liver Diseases
Gilead’s Lead Liver Disease Candidate Selonsertib Fails Phase III Trial in...
Liver Diseases
Shire Licenses Rare Liver Disease Candidates to $120M Startup Mirum
Liver Diseases
FDA Approves Alnylam’s Onpattro for Polyneuropathy of hATTR Amyloidosis
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
